UF Partners With National Radio Astronomy Observatory To Bring Cutting-Edge Astronomy and STEM Education to Florida
The University of Florida is teaming up with the National Science Foundation’s National Radio Astronomy Observatory (NSF NRAO) to bring a major science and education project to the state.
Chiller Body Joins UF Innovate | Accelerate
Chiller Body joins UF Innovate | Accelerate at The Hub to drive the global expansion of its patented cooling hat inserts.
Blackberries With No Thorns? UF Scientist Assembles Genome of a Blackberry in Major Step to Breeding Better Fruit
University of Florida researchers are enhancing blackberry nutrition by identifying metabolites that may increase antioxidants and anti-inflammatory properties in the fruit.
Oragenics, Inc. To Participate at the 15th Annual Traumatic Brain Injury Conference
UF Innovate | Accelerate graduate Oragenics, Inc., a biotechnology company developing novel intranasal therapies for concussion and other brain-related conditions, announced its participation in the 15th Annual Traumatic Brain Injury Conference.
Better Feed, Fewer Burps: UF Scientists Target Dairy Gas Emissions
UF researchers are testing a new type of cattle feed that could help dairy cows release less methane gas from burps and flatulence and use nutrients more efficiently.
TECDIA Launches Ultra-Fine kaikaFIN Nozzle for Mako Hotend in Partnership With Slice Engineering
Japanese precision machining company TECDIA Co., Ltd. has unveiled the kaikaFIN, a next-generation 3D printing nozzle designed for the Mako Hotend by UF Innovate | Accelerate client Slice Engineering.
The Fibrolamellar Cancer Foundation Establishes Partnership With Dialectic Therapeutics
UF startup Dialectic Therapeutics, in partnership with the Fibrolamellar Cancer Foundation (FCF), will supply the experimental drug DT2216 for a clinical trial involving fibrolamellar patients.
Popular Diabetes Medications May Protect Against Alzheimer’s Disease, UF Researchers Find
UF researchers have found that a pair of popular glucose-lowering medications may have protective effects against the development of Alzheimer’s disease and related dementias in patients with Type 2 diabetes.
UF Pharmacy Professor’s Paper Ranks No. 2 in Citations This Century
A paper co-authored by UF researcher Thomas Schmittgen has become the second most-cited research article of the 21st century and the fifth most-cited of all time, with nearly 150,000 citations, according to Nature.
Unraveling the Mysteries of Dark Energy at UF
UF researcher Zachary Slepian is leading the Dark Energy Spectroscopic Instrument’s efforts to map the cosmos, placing UF at the center of the largest cosmic map ever made.